|
|
| ITF Press Release |
| Decision in the case of Karol Beck |
London, GREAT BRITAIN, 13 Feb 2006 - The International Tennis Federation announced today that an independent Anti-Doping Tribunal convened under the Tennis Anti-Doping Programme has found that Karol Beck has committed a Doping Offence under the Programme.
The independent Anti-Doping Tribunal has ruled that Mr Beck, a 23-year-old from the Slovak Republic, committed a Doping Offence under Article C.1 of the Programme (presence of a Prohibited Substance in a sample), in that a sample that he provided on 24 September 2005 during the Davis Cup World Group semifinal tie between Slovak Republic and Argentina in Bratislava, tested positive for clenbuterol. Clenbuterol is classified by the WADA Code and the Tennis Anti-Doping Programme as an Anabolic Agent.
The independent Tribunal heard the matter in London on 17 January 2006. The Tribunal consisted of Mr Charles Flint QC, Dr Joe Cummiskey and Professor Vivian James. The Tribunal did not find that exceptional circumstances were proved and confirmed the commission of a Doping Offence.
Mr Beck’s results at the Davis Cup semifinal are automatically disqualified, however in accordance with the rules of the Davis Cup competition, in this instance the overall result of the semifinal shall not be re-assessed. Mr Beck’s ATP ranking points and prize money ($42,935) from all subsequent competitions are disqualified and forfeit. The Tribunal also imposed a period of ineligibility of two years which is deemed to have commenced on 1 November 2005.
Any party wishing to appeal the decision will have three weeks to do so from receipt of the written decision.
The Tennis Anti-Doping Programme is a comprehensive and internationally recognised drug-testing programme that applies to all players competing at tournaments sanctioned by the ITF, ATP and WTA Tour. The ITF tests at Grand Slams (men and women), Davis Cup and Fed Cup, ITF Men’s and Women’s Circuit, Junior and Wheelchair Tennis Events, and from 2006, manages the testing at all ATP-sanctioned events. The WTA Tour manages testing at WTA Tour events. Players are tested for substances prohibited by the World Anti-Doping Agency. Charges of breach of the Programme are heard by an independent Anti-Doping Tribunal.
The Tribunal's written decision with reasons is available below.
| The above documents are in Adobe Acrobat format. To view and print them you require the Acrobat Reader program installed on your computer. Click on the icon to download a free copy of the Reader. |  |
^ Back to Top
|
